Listen: Cannabis, Healthcare, and The Road Ahead for Investors - burst 4
"You go what are your five biggest healthcare stories of twenty nine thousand. I could probably just go get a sandwich and you because of all of the things that have gone on health health care this year. I'm not GonNa do that but I'm curious when you think back on twenty nineteen What stands out to you whether it's individual stories involving individual companies or trends? Ask Us there so much to cover in the healthcare space but I will give you kind kind of the big east so I think first and foremost twenty nineteen and really into twenty twenty is about personalized medicine precision medicine and in particular. If you're an investor you're going to be looking at the cancer space cancer second leading cause of death globally by twenty thirty three research. Researchers are expecting twenty one million new cases. This is a huge huge area But there was a report I believe released just yesterday from evaluate Pharma For Twenty Twenty Twenty eight drugs are expected to generate over a billion dollars in sales in two thousand twenty. Guess how many of those are for cancer drugs just Komo say at least half. You're exactly right. Half of those drugs are just for cancer. CARE so these are companies like Merck a big Bio Pharma Company. They've got their big blockbuster drug key true to Bristol Myers Squibb. Of course they did the acquisition with Cell Dri. Now they're an even more formidable foe in cancer care as well so that's one one area that I think all healthcare investors should be watching is on college e another one Chris"